Corneal immune privilege

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


This year marks the 100th anniversary of the first successful corneal transplant on a human subject. Corneal allografts enjoy an exceptionally high acceptance, with rejection occurring in less than 10% of the patients who have not previously received a corneal transplant and who do not have underlying ocular inflammation. Corneal grafts survive even though HLA typing and systemic immunosuppressive drugs are not employed. The remarkable success of corneal transplants is due to a combination of anatomical, physiological, and immunological properties that conspire to prevent the induction and expression of potentially destructive immune responses to the foreign transplant.

Original languageEnglish (US)
Pages (from-to)S158-S160
JournalOcular Surface
Issue number4
StatePublished - Oct 1 2005


  • Corneal transplantation
  • Graft rejection
  • Immune privilege
  • Keratoplasty

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Corneal immune privilege'. Together they form a unique fingerprint.

Cite this